Evidence map›Paper›PMID 27169346›Full record

ArticleCellular signalling2016

Phosphorylation of Src by phosphoinositide 3-kinase regulates beta-adrenergic receptor-mediated EGFR transactivation.

Lewis J Watson, Kevin M Alexander, Maradumane L Mohan, Amber L Bowman, Supachoke Mangmool, Kunhong Xiao, Sathyamangla V Naga Prasad, Howard A Rockman

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Lewis J WatsonDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, United States.
Kevin M AlexanderDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, United States.
Maradumane L MohanDepartment of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, United States.
Amber L BowmanDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, United States.
Supachoke MangmoolDepartment of Pharmacology, Faculty of Pharmacy, Mahidol University, Thailand.
Kunhong XiaoDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, United States; Department of Pharmacology and Chemical Biology, University of Pittsburg School of Medicine, Pittsburgh, PA 15261, United States.
Sathyamangla V Naga PrasadDepartment of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, United States. Electronic address: prasads2@ccf.org.
Howard A RockmanDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, United States; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, United States; Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, United States. Electronic address: h.rockman@duke.edu.
Duke Medical Center · USCleveland Clinic · USDuke University · USDuke University Hospital · USMahidol University · TH

Funding

Regulation of Beta-Adrenergic Receptor Signaling by S-NitrosylationP01HL075443 · NHLBI · DUKE UNIVERSITY · PI XIAO, KUNHONG · 2004 to 2019
$26.1M
MECHANISMS OF MALADAPTATION IN HEART FAILURER01HL056687 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI Howard A Rockman · 1996 to 2026
$12.3M
MULTIDISCIPLINARY HEART &VASCULAR DISEASEST32HL007101 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 1985 to 2020
$9.8M
Novel Regulation of Beta Andregenic Receptor FunctionR01HL089473 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PRASAD, SATHYAMANGLA V · 2008 to 2017
$3.7M
Live cell widefield fluorescence microscope with activation and bleaching lasersS10RR027528 · NCRR · DUKE UNIVERSITY · PI JOHNSON, SAM · 2010 to 2010
$423k
NCRR NIH HHS S10 RR027528NHLBI NIH HHS P01 HL075443NHLBI NIH HHS R01 HL056687NHLBI NIH HHS R01 HL089473NHLBI NIH HHS T32 HL007101
6 · The paper itself

Abstract

β2-Adrenergic receptors (β2AR) transactivate epidermal growth factor receptors (EGFR) through formation of a β2AR-EGFR complex that requires activation of Src to mediate signaling. Here, we show that both lipid and protein kinase activities of the bifunctional phosphoinositide 3-kinase (PI3K) enzyme are required for β2AR-stimulated EGFR transactivation. Mechanistically, the generation of phosphatidylinositol (3,4,5)-tris-phosphate (PIP3) by the lipid kinase function stabilizes β2AR-EGFR complexes while the protein kinase activity of PI3K regulates Src activation by direct phosphorylation. The protein kinase activity of PI3K phosphorylates serine residue 70 on Src to enhance its activity and induce EGFR transactivation following βAR stimulation. This newly identified function for PI3K, whereby Src is a substrate for the protein kinase activity of PI3K, is of importance since Src plays a key role in pathological and physiological signaling.

Indexed as

Amino Acid SequenceBiosensing TechniquesEndocytosisErbB ReceptorsHEK293 CellsHumansIsoproterenolMass SpectrometryModels, BiologicalPhosphatidylinositol 3-KinasesPhosphorylationPhosphoserineProto-Oncogene Proteins c-aktsrc-Family KinasesTranscriptional ActivationErbB ReceptorsIsoproterenolPhosphatidylinositol 3-KinasesPhosphoserineProto-Oncogene Proteins c-aktsrc-Family KinasesAdrenergic receptorEpidermal growth factor receptorPhosphatidylinositide 3-kinasePhosphorylationSrc

Identifiers

PMID27169346
PMCPMC4980165
OpenAlexW2374306663

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.